Status:

RECRUITING

Risks and Benefits of Scrotal Drainage in Penile Prosthesis Implant

Lead Sponsor:

A.O.U. Città della Salute e della Scienza

Conditions:

Erectile Dysfunction

Eligibility:

MALE

18-90 years

Phase:

NA

Brief Summary

The goal of this prospective randomized study is to demonstrate if the use of an external scrotal drainage in penile prosthetic surgery can reduce the risk of post-operative complications without incr...

Detailed Description

After being informed about the study, all patients give writted informed consent. After that they will be randomized in two groups (A with drainage, B without drainage) using a random sequence generat...

Eligibility Criteria

Inclusion

  • Written informed consent signed voluntarily according to the rules of good clinical practice (Declaration of Helsinki) and national regulations (Appendix B).
  • Genetically male patient.
  • Age ≥ 18 years.
  • Patient suffering from ED of variable and/or multifactorial etiology.
  • Patient suffering from ED not responsive to iPDE-5.
  • Patient suffering from unresponsive or non-tolerant ED

Exclusion

  • Absence of signed written informed consent (Appendix B).
  • Age \<18 years.
  • Genetically female patients.
  • Patient with active peno-scrotal infection.
  • Patient with active systemic infection.
  • Immunosuppressed patient.
  • Patient with haematological pathologies that may cause an increased risk of bleeding.
  • Patients suffering from Peyronie's Disease who must undergo simultaneous plaque surgery.
  • Any condition or situation that, in the opinion of the investigator, places the patient at significant risk, may confound the results of the study, or significantly interfere with the patient's participation in the study.
  • The patient declares that it will be impossible for him to participate in follow-up consultations.

Key Trial Info

Start Date :

October 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2033

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06147791

Start Date

October 1 2023

End Date

October 1 2033

Last Update

January 24 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

SCDU Urologia

Torino, Torino, Italy, 10126

2

A.O.U. Città della Salute e della Scienza di Torino

Turin, Turin, Italy, 10126